Nishadil
Signup Signin
Delhi | 25°C (windy)
Cagrisema: Novo Nordisk's Dual-Action Powerhouse Poised to Revolutionize Obesity Treatment

Cagrisema: Novo Nordisk's Dual-Action Powerhouse Poised to Revolutionize Obesity Treatment
Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s

Pfizer's Bold Gambit: Unlocking the Future of Obesity Treatment with Metsera and Oral GLP-1s
Novo Nordisk's Strategic Overhaul: 9,000 Job Cuts to Propel Future Dominance

Novo Nordisk's Strategic Overhaul: 9,000 Job Cuts to Propel Future Dominance
Viking Therapeutics' Oral Weight Loss Drug Stumbles: VK2735 Data Leaves Investors Underwhelmed

Viking Therapeutics' Oral Weight Loss Drug Stumbles: VK2735 Data Leaves Investors Underwhelmed
Load more..